Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model.
Citrullinated protein
Dysbiosis
Periodontitis
Porphyromonas gingivalis
Rheumatoid arthritis
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
19 10 2020
19 10 2020
Historique:
received:
07
01
2020
accepted:
07
10
2020
entrez:
20
10
2020
pubmed:
21
10
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Porphyromonas gingivalis (Pg) infection causes periodontal disease and exacerbates rheumatoid arthritis (RA). It is reported that inoculation of periodontopathogenic bacteria (i.e., Pg) can alter gut microbiota composition in the animal models. Gut microbiota dysbiosis in human has shown strong associations with systemic diseases, including RA, diabetes mellitus, and inflammatory bowel disease. Therefore, this study investigated dysbiosis-mediated arthritis by Pg oral inoculation in an experimental arthritis model mouse. Pg inoculation in the oral cavity twice a week for 6 weeks was performed to induce periodontitis in SKG mice. Concomitantly, a single intraperitoneal (i.p.) injection of laminarin (LA) was administered to induce experimental arthritis (Pg-LA mouse). Citrullinated protein (CP) and IL-6 levels in serum as well as periodontal, intestinal, and joint tissues were measured by ELISA. Gut microbiota composition was determined by pyrosequencing the 16 s ribosomal RNA genes after DNA purification of mouse feces. Fecal microbiota transplantation (FMT) was performed by transferring Pg-LA-derived feces to normal SKG mice. The effects of Pg peptidylarginine deiminase (PgPAD) on the level of citrullinated proteins and arthritis progression were determined using a PgPAD knockout mutant. Periodontal alveolar bone loss and IL-6 in gingival tissue were induced by Pg oral infection, as well as severe joint destruction, increased arthritis scores (AS), and both IL-6 and CP productions in serum, joint, and intestinal tissues. Distribution of Deferribacteres and S24-7 was decreased, while CP was significantly increased in gingiva, joint, and intestinal tissues of Pg-inoculated experimental arthritis mice compared to experimental arthritis mice without Pg inoculation. Further, FMT from Pg-inoculated experimental arthritis mice reproduced donor gut microbiota and resulted in severe joint destruction with increased IL-6 and CP production in joint and intestinal tissues. The average AS of FMT from Pg-inoculated experimental arthritis was much higher than that of donor mouse. However, inoculation of the PgPAD knockout mutant inhibited the elevation of arthritis scores and ACPA level in serum and reduced CP amount in gingival, joint, and intestinal tissues compared to Pg wild-type inoculation. Pg oral infection affected gut microbiota dysbiosis and joint destruction via increased CP generation.
Sections du résumé
BACKGROUND
Porphyromonas gingivalis (Pg) infection causes periodontal disease and exacerbates rheumatoid arthritis (RA). It is reported that inoculation of periodontopathogenic bacteria (i.e., Pg) can alter gut microbiota composition in the animal models. Gut microbiota dysbiosis in human has shown strong associations with systemic diseases, including RA, diabetes mellitus, and inflammatory bowel disease. Therefore, this study investigated dysbiosis-mediated arthritis by Pg oral inoculation in an experimental arthritis model mouse.
METHODS
Pg inoculation in the oral cavity twice a week for 6 weeks was performed to induce periodontitis in SKG mice. Concomitantly, a single intraperitoneal (i.p.) injection of laminarin (LA) was administered to induce experimental arthritis (Pg-LA mouse). Citrullinated protein (CP) and IL-6 levels in serum as well as periodontal, intestinal, and joint tissues were measured by ELISA. Gut microbiota composition was determined by pyrosequencing the 16 s ribosomal RNA genes after DNA purification of mouse feces. Fecal microbiota transplantation (FMT) was performed by transferring Pg-LA-derived feces to normal SKG mice. The effects of Pg peptidylarginine deiminase (PgPAD) on the level of citrullinated proteins and arthritis progression were determined using a PgPAD knockout mutant.
RESULTS
Periodontal alveolar bone loss and IL-6 in gingival tissue were induced by Pg oral infection, as well as severe joint destruction, increased arthritis scores (AS), and both IL-6 and CP productions in serum, joint, and intestinal tissues. Distribution of Deferribacteres and S24-7 was decreased, while CP was significantly increased in gingiva, joint, and intestinal tissues of Pg-inoculated experimental arthritis mice compared to experimental arthritis mice without Pg inoculation. Further, FMT from Pg-inoculated experimental arthritis mice reproduced donor gut microbiota and resulted in severe joint destruction with increased IL-6 and CP production in joint and intestinal tissues. The average AS of FMT from Pg-inoculated experimental arthritis was much higher than that of donor mouse. However, inoculation of the PgPAD knockout mutant inhibited the elevation of arthritis scores and ACPA level in serum and reduced CP amount in gingival, joint, and intestinal tissues compared to Pg wild-type inoculation.
CONCLUSION
Pg oral infection affected gut microbiota dysbiosis and joint destruction via increased CP generation.
Identifiants
pubmed: 33076980
doi: 10.1186/s13075-020-02348-z
pii: 10.1186/s13075-020-02348-z
pmc: PMC7574451
doi:
Substances chimiques
Protein-Arginine Deiminases
EC 3.5.3.15
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
249Subventions
Organisme : NIDCR NIH HHS
ID : R01 DE029709
Pays : United States
Organisme : NIDCR NIH HHS
ID : R15 DE027851
Pays : United States
Organisme : NIDCR NIH HHS
ID : DE029709
Pays : United States
Organisme : NIDCR NIH HHS
ID : DE027851
Pays : United States
Références
BMC Musculoskelet Disord. 2016 May 05;17:205
pubmed: 27150598
mSphere. 2018 Oct 17;3(5):
pubmed: 30333180
J Clin Invest. 2004 Aug;114(4):582-8
pubmed: 15314695
PLoS One. 2008 Jul 30;3(7):e2836
pubmed: 18665274
Arthritis Rheumatol. 2016 Nov;68(11):2646-2661
pubmed: 27333153
J Exp Med. 2005 Mar 21;201(6):949-60
pubmed: 15781585
J Alzheimers Dis. 2018;66(1):105-114
pubmed: 30223397
Compend Suppl. 1994;(18):S684-5, 688-93; quiz S714-7
pubmed: 8039206
Arthritis Rheumatol. 2017 May;69(5):964-975
pubmed: 27863183
J Transl Med. 2018 Jul 31;16(1):214
pubmed: 30064459
PLoS One. 2015 Jul 28;10(7):e0134234
pubmed: 26218067
Oral Dis. 2015 Jul;21(5):626-33
pubmed: 25703825
Immunol Rev. 2010 Jan;233(1):34-54
pubmed: 20192991
J Immunol Res. 2017;2017:4835189
pubmed: 28948174
Oral Microbiol Immunol. 2007 Jun;22(3):208-15
pubmed: 17488448
Cell Signal. 2013 Oct;25(10):2069-78
pubmed: 23602936
Nat Rev Rheumatol. 2011 Jun 07;7(7):391-8
pubmed: 21647203
J Clin Med. 2019 Oct 22;8(10):
pubmed: 31652577
BMC Immunol. 2017 Jan 6;18(1):2
pubmed: 28061847
PLoS One. 2014 Jun 24;9(6):e100838
pubmed: 24959715
RMD Open. 2019 Jun 21;5(2):e000853
pubmed: 31321075
Rheum Dis Clin North Am. 2012 May;38(2):405-26
pubmed: 22819092
J Oral Microbiol. 2019 Mar 18;11(1):1586422
pubmed: 30911359
Eur J Immunol. 2005 May;35(5):1643-52
pubmed: 15832289
Arthritis Rheumatol. 2015 May;67(8):2020-31
pubmed: 25892475
Arthritis Res Ther. 2004;6(2):R142-50
pubmed: 15059278
Genome Biol. 2012 Jun 14;13(6):R42
pubmed: 22698087
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Appl Environ Microbiol. 2002 Nov;68(11):5445-51
pubmed: 12406736
J Periodontol. 2008 Aug;79(8 Suppl):1585-91
pubmed: 18673014
Nat Rev Rheumatol. 2014 Nov;10(11):645-53
pubmed: 25072264
Mol Oral Microbiol. 2018 Feb;33(1):68-80
pubmed: 28972686
Ann Vasc Surg. 2016 May;33:265
pubmed: 26965810
Trends Immunol. 2014 Jan;35(1):3-11
pubmed: 24269668
Transl Gastroenterol Hepatol. 2019 May 25;4:40
pubmed: 31231707
J Matern Fetal Neonatal Med. 2018 Mar;31(5):597-602
pubmed: 28282773
Sci Rep. 2017 Aug 15;7(1):8246
pubmed: 28811641
Arthritis Res Ther. 2009;11(5):249
pubmed: 19835638
Nat Rev Rheumatol. 2009 Apr;5(4):218-24
pubmed: 19337286
Arthritis Res Ther. 2018 Nov 03;20(1):247
pubmed: 30390695
J Immunol. 2001 Mar 15;166(6):4177-84
pubmed: 11238669
ILAR J. 2015;56(2):169-78
pubmed: 26323627
Microbiol Immunol. 2019 Jan;63(1):11-20
pubmed: 30599082
Nature. 2003 Nov 27;426(6965):454-60
pubmed: 14647385
J Periodontol. 2009 Apr;80(4):535-40
pubmed: 19335072
BMC Gastroenterol. 2012 Feb 16;12:16
pubmed: 22340817
Arthritis Rheum. 2010 Sep;62(9):2662-72
pubmed: 20506214
J Clin Periodontol. 1994 Jul;21(6):375-9
pubmed: 8089237
Sci Rep. 2014 May 06;4:4828
pubmed: 24797416
BMJ. 2018 Jan 8;360:j5145
pubmed: 29311119
Sci Rep. 2017 Jul 31;7(1):6955
pubmed: 28761156
Clin Exp Immunol. 2019 Jan;195(1):74-85
pubmed: 29920643
Appl Environ Microbiol. 1999 Aug;65(8):3287-92
pubmed: 10427008
J Periodontol. 2005 Nov;76(11 Suppl):2033-41
pubmed: 16277573
Arthritis Rheumatol. 2015 Mar;67(3):656-67
pubmed: 25470448
Arthritis Rheum. 2009 Nov 15;61(11):1472-83
pubmed: 19877103
Eur J Oral Sci. 2018 Oct;126 Suppl 1:26-36
pubmed: 30178551
Clin Exp Immunol. 2016 Nov;186(2):177-189
pubmed: 27465496
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
J Immunol. 2014 Jul 15;193(2):849-59
pubmed: 24951817
Int J Mol Med. 2015 Aug;36(2):565-70
pubmed: 26082376
Arthritis Res Ther. 2005;7(6):R1421-9
pubmed: 16277695